These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9189650)

  • 1. Clinical trials and tribulations: a personal view of interacting with pharmaceutical manufacturers.
    Scheifele DW
    Clin Invest Med; 1997 Jun; 20(3):188-92. PubMed ID: 9189650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.
    Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C
    Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ethics in researcher-research promotor relations].
    Ribeiro C
    Acta Med Port; 1992 Apr; 5(4):226-30. PubMed ID: 1605075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industry sponsorship and authorship of clinical trials over 20 years.
    Buchkowsky SS; Jewesson PJ
    Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
    Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers: What can we learn from clinical research?
    Eichler HG; Kong SX; Grégoire JP
    Eur J Health Econ; 2006 Jun; 7(2):129-35. PubMed ID: 16485122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of pharmaceutical industry funding on clinical research.
    Lexchin JR
    Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partnership between academia and industry for drug discovery in Alzheimer's disease.
    Ivinson AJ; Lane R; May PC; Hosford DA; Carrillo MC; Siemers ER
    Alzheimers Dement; 2008 Mar; 4(2):80-8. PubMed ID: 18631952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Coordinating Centers for Clinical Trials (KKS) and the KKS Network: competence for clinical research].
    Ohmann C; Bruns I; Wolff S
    Onkologie; 2010; 33 Suppl 7():11-5. PubMed ID: 20926908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry.
    Henry D; Doran E; Kerridge I; Hill S; McNeill PM; Day R
    Arch Intern Med; 2005 Nov; 165(21):2493-6. PubMed ID: 16314546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases?
    Liyanage SS; Raina Macintyre C
    Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boom in clinical research industry: a dangerous trend.
    Bajpai V; Saraya A
    Trop Gastroenterol; 2009; 30(3):177-81. PubMed ID: 20306757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethics and industry-sponsored research.
    Kuebler C; Nimmo WS; von R; Gillings D; Morgan AT; Kendle C; Covington PS
    CMAJ; 2002 Mar; 166(5):579-80; author reply 582. PubMed ID: 11898930
    [No Abstract]   [Full Text] [Related]  

  • 15. Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship.
    Liss H
    Isr Med Assoc J; 2006 Jul; 8(7):451-4. PubMed ID: 16889157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on cancer diagnosis in Malaysia: current status.
    Looi LM; Zubaidah Z; Cheah PL; Cheong SK; Gudum HR; Iekhsan O; Ikram SI; Jamal R; Mak JW; Othman NH; Puteri JN; Rosline H; Sabariah AR; Seow HF; Sharifah NA;
    Malays J Pathol; 2004 Jun; 26(1):13-27. PubMed ID: 16190103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discovery dilemma and Cura quartet collaboration.
    Shah S; Federoff HJ
    Drug Discov Today; 2009 Nov; 14(21-22):1006-10. PubMed ID: 19815089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages].
    ten Cate JW; Büller HR
    Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1572-6. PubMed ID: 10443284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post launch studies].
    Akaza H; Ohashi Y; Shimada Y; Ikeda T; Saijo N; Isonishi S; Hirao Y; Tsuruo T; Tsukagoshi S; Sone S; Nakamura S; Kato M; Mikami O; von Euler M; Blackledge G; Milsted B; Vose B
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):2037-48. PubMed ID: 12465411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industry-sponsored research.
    Okike K; Kocher MS; Mehlman CT; Bhandari M
    Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.